LV10949B - Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation - Google Patents

Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation Download PDF

Info

Publication number
LV10949B
LV10949B LVP-93-1042A LV931042A LV10949B LV 10949 B LV10949 B LV 10949B LV 931042 A LV931042 A LV 931042A LV 10949 B LV10949 B LV 10949B
Authority
LV
Latvia
Prior art keywords
formula
compound
preparation
hjih
compounds
Prior art date
Application number
LVP-93-1042A
Other languages
English (en)
Latvian (lv)
Other versions
LV10949A (lv
Inventor
Anna-Lena Ask
Rune Verner Sandberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10949A publication Critical patent/LV10949A/xx
Publication of LV10949B publication Critical patent/LV10949B/lv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
LVP-93-1042A 1989-12-21 1993-08-27 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation LV10949B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8904298A SE8904298D0 (sv) 1989-12-21 1989-12-21 New compounds
PCT/SE1990/000818 WO1991009845A1 (en) 1989-12-21 1990-12-17 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation

Publications (2)

Publication Number Publication Date
LV10949A LV10949A (lv) 1995-12-20
LV10949B true LV10949B (en) 1996-06-20

Family

ID=20377821

Family Applications (2)

Application Number Title Priority Date Filing Date
LVP-93-1042A LV10949B (en) 1989-12-21 1993-08-27 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
LV960262A LV5766B4 (lv) 1989-12-21 1996-07-17 Aizvietoti 4-fenil-4-piperidinkarboksamidi ar lokalu anestezejosu un analgetisku daribu ka ari to iegusanas metodes

Family Applications After (1)

Application Number Title Priority Date Filing Date
LV960262A LV5766B4 (lv) 1989-12-21 1996-07-17 Aizvietoti 4-fenil-4-piperidinkarboksamidi ar lokalu anestezejosu un analgetisku daribu ka ari to iegusanas metodes

Country Status (40)

Country Link
US (2) US5227389A (no)
EP (1) EP0506778B1 (no)
JP (1) JP2656152B2 (no)
KR (1) KR0179382B1 (no)
CN (1) CN1037841C (no)
AT (1) ATE138650T1 (no)
AU (1) AU647068B2 (no)
BG (1) BG60912B1 (no)
BR (1) BR1100379A (no)
CA (1) CA2069608C (no)
CZ (1) CZ278035B6 (no)
DE (1) DE69027221T2 (no)
DK (1) DK0506778T3 (no)
DZ (1) DZ1468A1 (no)
EG (1) EG19361A (no)
ES (1) ES2087280T3 (no)
FI (1) FI100881B (no)
HK (1) HK22997A (no)
HR (1) HRP920591B1 (no)
HU (1) HU213110B (no)
IE (1) IE74855B1 (no)
IL (1) IL96636A (no)
IS (1) IS1664B (no)
LT (1) LT4005B (no)
LV (2) LV10949B (no)
NO (1) NO178858C (no)
NZ (1) NZ236293A (no)
PL (1) PL163591B1 (no)
PT (1) PT96303B (no)
RO (1) RO112864B1 (no)
RU (1) RU2039043C1 (no)
SA (1) SA91110209B1 (no)
SE (1) SE8904298D0 (no)
SG (1) SG46413A1 (no)
SI (1) SI9012346B (no)
SK (1) SK658190A3 (no)
UA (1) UA26403A (no)
WO (1) WO1991009845A1 (no)
YU (1) YU48086B (no)
ZA (1) ZA909903B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3916092B2 (ja) * 1993-09-17 2007-05-16 杏林製薬株式会社 イミダゾリジノン誘導体とその酸付加塩及び老年性痴呆症の治療薬
SE9400447D0 (sv) * 1994-02-11 1994-02-11 Astra Ab New compounds
SE9404438D0 (sv) * 1994-12-21 1994-12-21 Astra Ab New process
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US20020102291A1 (en) * 1997-12-15 2002-08-01 Noven Pharmaceuticals, Inc. Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
AR035234A1 (es) * 2001-04-12 2004-05-05 Pharmacopeia Drug Discovery Aril y biaril-piperidinas con actividad moduladora mch, metodo para preparar dichos compuestos, composiciones farmaceuticas, metodo para preparar las composiciones farmaceuticas y el uso de dichos compuestos para la manufactura de un medicamento
MXPA05006354A (es) * 2002-12-13 2005-08-26 Smithkline Beecham Corp Antagonistas ccr5 como agentes terapeuticos.
TW200831497A (en) * 2006-10-12 2008-08-01 Epix Delaware Inc Carboxamide compounds and their use
JP2011506466A (ja) 2007-12-11 2011-03-03 株式会社サイトパスファインダー カルボキサミド化合物ならびにケモカイン受容体アゴニストとしてのそれらの使用
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
EP3914246A1 (en) 2019-01-22 2021-12-01 ICM (Institut du Cerveau et de la Moelle Épinière) Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE96980C1 (no)
US2486796A (en) * 1943-06-25 1949-11-01 Ciba Pharm Prod Inc Esters of 1-alkyl-4-hydroxyphenylpiperidyl-4-ketones
US3334106A (en) * 1964-10-20 1967-08-01 Aldrich Chem Co Inc N(aryl)n(hydrocarbyl)-omega-(4-phenyl-4-piperidinocarbonylheteroamine) alkanoamide
US3539580A (en) * 1967-06-26 1970-11-10 Janssen Pharm 4-aryl-4-aminoalkoxy-piperidines
CH501622A (de) * 1968-12-20 1971-01-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Piperidinderivaten
US3737538A (en) * 1968-12-30 1973-06-05 Ciba Geigy Corp Antitussive compositions and method with isonipecotic acid derivatives
FR2156470A2 (en) * 1971-10-21 1973-06-01 Synthelabo 1-(3,3-diphenyl-1-propyl)-4-aryl-piperidines - as analgesics spasmolytic and anti-tussive agents
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
US5100903A (en) * 1989-05-12 1992-03-31 Anaquest, Inc. N-aryl-n-(1-substituted-3-alkoxy-4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds

Also Published As

Publication number Publication date
DZ1468A1 (fr) 2004-09-13
IL96636A0 (en) 1991-09-16
HU213110B (en) 1997-02-28
JPH05502869A (ja) 1993-05-20
HU9202044D0 (en) 1992-09-28
NO178858C (no) 1996-06-19
DK0506778T3 (da) 1996-10-07
LV10949A (lv) 1995-12-20
JP2656152B2 (ja) 1997-09-24
SE8904298D0 (sv) 1989-12-21
HRP920591B1 (en) 1998-12-31
US5227389A (en) 1993-07-13
FI922806A (fi) 1992-06-17
BG60912B1 (bg) 1996-06-28
WO1991009845A1 (en) 1991-07-11
US5360805A (en) 1994-11-01
ZA909903B (en) 1991-08-28
CZ658190A3 (en) 1993-01-13
SA91110209B1 (ar) 2004-05-08
AU6978391A (en) 1991-07-24
IE904534A1 (en) 1991-07-03
NZ236293A (en) 1992-10-28
CA2069608A1 (en) 1991-06-22
FI100881B (fi) 1998-03-13
SI9012346A (sl) 1998-08-31
LV5766B4 (lv) 1997-06-20
HK22997A (en) 1997-02-27
KR0179382B1 (ko) 1999-03-20
FI922806A0 (fi) 1992-06-17
RU2039043C1 (ru) 1995-07-09
YU48086B (sh) 1997-01-08
IS3659A7 (is) 1991-06-22
NO178858B (no) 1996-03-11
HRP920591A2 (en) 1997-08-31
ES2087280T3 (es) 1996-07-16
SG46413A1 (en) 1998-02-20
CN1053605A (zh) 1991-08-07
AU647068B2 (en) 1994-03-17
NO922380L (no) 1992-06-17
CA2069608C (en) 2001-07-10
IE74855B1 (en) 1997-08-13
EG19361A (en) 1994-12-30
EP0506778B1 (en) 1996-05-29
SK278283B6 (en) 1996-08-07
RO112864B1 (ro) 1998-01-30
LTIP1731A (en) 1995-07-25
NO922380D0 (no) 1992-06-17
PL163591B1 (pl) 1994-04-29
CZ278035B6 (en) 1993-07-14
BR1100379A (pt) 1999-12-07
PT96303A (pt) 1991-09-30
IL96636A (en) 1994-11-28
LV5766A4 (lv) 1996-12-20
PL288409A1 (en) 1991-12-02
KR927003531A (ko) 1992-12-18
DE69027221D1 (de) 1996-07-04
HUT64518A (en) 1994-01-28
SK658190A3 (en) 1996-08-07
ATE138650T1 (de) 1996-06-15
DE69027221T2 (de) 1996-10-10
UA26403A (uk) 1999-08-30
SI9012346B (sl) 1999-08-31
PT96303B (pt) 1998-07-31
EP0506778A1 (en) 1992-10-07
YU234690A (sh) 1993-10-20
CN1037841C (zh) 1998-03-25
IS1664B (is) 1997-07-04
LT4005B (en) 1996-07-25

Similar Documents

Publication Publication Date Title
LV10949B (en) Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
FI120235B (fi) Uusien terapeuttisesti aktiivisten bi- ja trisyklisten aminoalkoholien estereiden valmistusmenetelmä
AT370420B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
EP0600949B1 (de) Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel
EP0282959A3 (en) Substituted 9-amino-tetrahydro-acridines and related compounds, a process for their preparation and their use as medicaments
JP3587862B2 (ja) 原生動物感染症の治療時の経口又は局所投与用薬剤の製造方法
HUT69391A (en) Pregnanes and androstanes substituted by 2-beta-morpholine derivatives and pharmaceutical compositions containing the same and process for their production
CH655118A5 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und antibakterielle mittel, die diese verbindungen enthalten.
EP0137441A2 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
PT73791A (en) Process for preparing 2-carbamimidoyl-6-substituted-1- -carbadethiapen-2-em-3-carboxylic acids
DE3031791C2 (no)
DE3702755A1 (de) 3,5-di-tert.-butyl-4-hydroxybenzoesaeureamid, verschiedene von dessen derivaten, verfahren zur herstellung dieser verbindungen, die sie enthaltenden arzneimittel und ihre verwendung
AT402928B (de) Neues verfahren zur herstellung von cefotaxim
EP0104614A1 (en) Phenylpiperazine derivatives and process for producing the same
EP0110869A1 (de) Thienylessigsäureamidderivate und pharmazeutisch verträgliche Säureadditionssalze hiervon sowie Verfahren zu deren Herstellung
US4464384A (en) 2-Phenylimidazo[2,1-b]benzothiazole compounds, salts thereof, process of producing them, and pharmaceutical compositions containing them
US4521417A (en) Geranylgeranylacetamide compounds having a piperazine ring, salts thereof, pharmaceutical compositions containing said compounds, and method of treating ulcers in mammals
EP0402806A1 (de) Kristalline Cephem Säureadditionssalze und Verfahren zu ihrer Herstellung
AU650074B2 (en) 9-halogen-11beta -hydroxy prostaglandin derivative, process for producing it and its use as a medicament
EP0105458B1 (en) Alpha-aryl-alpha-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
DE60015177T2 (de) Verfahren zur herstellung von 2-[4-(alpha-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxyessigsäure und zwischenprodukte dafür
US3793322A (en) 1,4-disubstituted piperazines
DD247217A5 (de) Verfahren zur herstellung von 2,6,-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridin-3,5-dicarbonsaeure-3 beta (n-benzyl-n-methylamino)-ethylester-5-methylester und dessen hydrochlorid-salz
DE4233586A1 (de) 3-Imino-3-alkoxy-propionsäurelactate und deren tautomere Acrylsäurelactate
DE2644335A1 (de) 2-niedrig-alkyl-7-subst.-2- oder -3-cephem-4-carbonsaeureverbindungen und verfahren zu ihrer herstellung